The White House administration stated that they are still confident in the COVID-19 test that is used to test President Trump and staff daily despite a new study from New York University showing it may be missing nearly 50 percent of infections.
“We still have confidence in the test or we wouldn’t have it on the market,” Department of Health and Human Services Secretary Alex Azar said Friday on Fox Business.
In a new study from New York University, which has not yet been peer-reviewed, the Abbott ID NOW test missed 48 percent of positive cases when using dry nasal swabs.
According to CNBC, Abbott denied the result from the study, adding that the samples were tested incorrectly, with Azar also saying on Friday that the alarming results could have been caused by “user error.”
Meanwhile, the Food & Drug Administration issued a notice Thursday alerting the public about potential inaccurate results. The FDA is working with Abbott to analyze the information and said negative test results that are not consistent with a patient’s symptoms should be confirmed with another test.
The FDA is also looking into whether the missed positives could be due to the types of swabs and materials used.
“What we’re saying is that there are some data to suggest that there may be inaccuracies, false negatives, with the Abbott test. However, there are many users who have contacted us and have not had this problem, so FDA is digging into it, and we’re working with Abbott to actually look at what data are available to get the most up to date and accurate information about the test performance,” FDA Commissioner Stephen Hahn said on “CBS This Morning” Friday.
“That being said, the test is on the market. We continue to recommend its use or to have it available for use,” he added.
Be the first to comment